TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients

Research output: Contribution to journalArticlepeer-review


Background: Single-nucleotide polymorphisms within TP53 gene (codon 72 exon 4, rs1042522, encoding either arginine or proline) and MDM2 promoter (SNP309; rs2279744), have been independently associated with increased risk of several cancer types. Few studies have analysed the role of these polymorphisms in the development of hepatocellular carcinoma. Methods. Genotype distribution of TP53 codon 72 and MDM2 SNP309 in 61 viral hepatitis-related hepatocellular carcinoma cases and 122 blood samples (healthy controls) from Italian subjects were determined by PCR and restriction fragment length polymorphism (RFLP). Results: Frequencies of TP53 codon 72 alleles were not significantly different between cases and controls. A significant increase of MDM2 SNP309 G/G and T/G genotypes were observed among hepatocellular carcinoma cases (Odds Ratio, OR = 3.56, 95% Confidence Limits, 95% CI = 1.3-9.7; and OR = 2.82, 95% CI = 1.3-6.4, respectively). Conclusions: These results highlight a significant role of MDM2 SNP309 G allele as a susceptibility gene for the development of viral hepatitis-related hepatocellular carcinoma among Italian subjects.

Original languageEnglish
Article number13
JournalInfectious Agents and Cancer
Issue number1
Publication statusPublished - 2011


  • Genetic Polymorphisms
  • hepatocellular carcinoma
  • MDM2 SNP309
  • TP53 codon 72

ASJC Scopus subject areas

  • Infectious Diseases
  • Oncology
  • Epidemiology
  • Cancer Research


Dive into the research topics of 'TP53 and MDM2 gene polymorphisms and risk of hepatocellular carcinoma among Italian patients'. Together they form a unique fingerprint.

Cite this